Chair
Dipak Panigrahy, MD
Beth Israel Deaconess Medical Center/Harvard Medical School
Co-Chair
Alexander Sougiannis, BS, MA
University of South Carolina School of Medicine
Session Description: Unresolved inflammation is a major mechanism of pathogenesis in many human diseases. A paradigm shift is emerging in our understanding of the pathogenesis of inflammation which results not only from persistent activation of inflammatory signals, but also from the active loss of pro-resolution mechanisms. Differentiating between the suppression and resolution of inflammation driven by pro-resolution mediators is critical for the treatment of various inflammatory diseases.
| Chair - Welcome and Introductions | ||
| 2:00 PM - 2:45 PM | Resolvins and Novel Pro-Resolving Mediators (SPM) are Immunoresolvent Agonists Charles N. Serhan, PhD • Brigham and Women's Hospital/Harvard Medical School |
 |
| 2:45 PM - 3:30 PM | Dysregulation of Resolution in Atherosclerosis Gabrielle Fredman, PhD • Albany Medical College |
 |
| 3:30 PM - 4:15 PM | Pro-resolving Mediators as Novel Diagnostic and Prognostic Biomarkers for Personalized Medicines Jesmond Dalli, PhD, FHEA • BARTS and the London School of Medicine and Dentistry, London, England |
 |
| 4:15 PM - 5:00 PM | Pro-resolving Lipid Mediators in Tissue Repair Matthew Spite, PhD • Brigham and Women’s Hospital/Harvard Medical School |
 |
| Questions and Answers |